USPTO 2015–2025 USPTO PatentsView US Corporation

Reliant Immune Diagnostics, Inc.

USPTO PatentsView assignee record - 44 granted patents across 18 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02A (Technologies FOR Adaptation TO Climate Change).

RSS updates for this company

The verdict

According to USPTO PatentsView, Reliant ranks #7,466 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 18 technology areas.

#7,466
of 49,997 US assignees by volume
Top 30%
by Innovation Score (42.8/100)
14.3
avg claims per patent
+900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7466 · US Corporation #7,466 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 44 grants
  • UPPER-Q #7,466/49,997
  • PHOTO-FINISH Prismatic Sensors AB
  • CPC-FOCUS Y02A · 18 areas
  • INNOV-PAR 42.8/100
  • CLAIMS-RICH 14.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +900% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Prismatic Sensors AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Reliant’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Reliant

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Reliant's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Reliant?

Each dot is one of Reliant’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Reliant’s own 14.3 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Reliant vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 43.944.044.04444.044.044.1 101520253035 Granted patents (volume) Avg claims / patent Prismatic Sensors AB - 44, 18.36Prismatic Sensors…Protochips, Inc. - 44, 16.82ProtochipsPulse Biosciences, Inc. - 44, 24.7Pulse BiosciencesRegulus Therapeutics Inc. - 44, 19.25Regulus Therapeut…Roehm GmbH - 44, 12.75RoehmRondo Energy, Inc. - 44, 31.68Rondo EnergySAFT - 44, 16.7SAFTSenju Pharmaceutical Co., Ltd. - 44, 12.18Senju Pharmaceuti…Reliant Immune Diagnostics, Inc. - 44, 14.3Reliant Immune Di…
Reliant vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Reliant's grants concentrate

Reliant Immune Diagnostics, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 70.5% of grants classified under Y02A (Technologies FOR Adaptation TO Climate Change). Peak complete grant year is 2021 (15 grants) versus a trough of 2 in 2018. By volume, Reliant sits between Prismatic Sensors AB and Senju Pharmaceutical Co., Ltd..

Reliant's three-year grant acceleration

From 2019–2021 to 2022–2024, Reliant Immune Diagnostics, Inc. moved from 22 to 20 grants (0.91x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Reliant's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Reliant holds 44 patents at rank #7,466, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Reliant

By rank, the assignees closest to #7,466 in granted patent volume.

Leaders in Y02A (Technologies FOR Adaptation TO Climate Change)

Other assignees with the most granted patents in Reliant's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Reliant, neither rank-band nor same-CPC leaders (those blocks stay above). In Y02A (Technologies FOR Adaptation TO Climate Change), Reliant ranks #99 of 3,645 assignees by patent count in that subclass.

Reliant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2018201920202021202220232024 4
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Reliant Immune Diagnostics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 4.5%
2019 2 4.5%
2020 5 11.4%
2021 15 34.1%
2022 6 13.6%
2023 10 22.7%
2024 4 9.1%

Which technologies does Reliant Immune Diagnostics, Inc. patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Reliant Immune Diagnostics, Inc.'s patent record in context - here's where to go next.

  • Reliant Immune Diagnostics, Inc.'s lead technology class is Y02A (Technologies FOR Adaptation TO Climate Change), 70.5% of its portfolio - see every assignee active in that class. Explore Y02A
  • Ranked #7,466 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Reliant Immune Diagnostics, Inc. against Prismatic Sensors AB, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.